Comparison

APP/beta-Amyloid (phospho-T668) polyclonal antibody

Manufacturer Bioworld Technology, Inc
Category
Type Antibody Polyclonal
Specific against Human, Mouse, Rat
Applications WB, IHC
Amount 100ul
Host Rabbit
Item no. BS4214-100
Targets APP
eClass 6.1 32160702
eClass 9.0 32160702
Available
Swiss-Prot
P05067
Application all
WB: 1:500ca.1:1000
IHC: 1:50ca.1:200
Background
Proteolytic cleavage of the Amyloid protein precursor (APP) gives rise to the beta-Amyloid and Amyloid A4 proteins, which are present in human platelets. Amyloid deposition is associated with type II diabetes, Down syndrome and a variety of neurological disorders, including Alzheimer's disease. The Amyloid precursor protein (APP) undergoes alternative splicing, resulting in several isoforms. Proteolytic cleavage of APP leads to the formation of the Amyloid beta/A4 Amyloid protein. This protein is involved in the formation of neurofibrillary tangles and plaques that characterize the senile plaques of Alzheimer's patients. APLP1 (Amyloid precursor-like protein 1) and APLP2 are structurally similar to APP.
Product
1 mg/ml in Phosphate buffered saline (PBS) with 0.05% sodium azide, approx. pH 7.2.
Purification and Purity
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Storage and Stability
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Specificity
p-APP/beta-Amyloid (T668) pAb detects endogenous levels of APP695 protein only when phosphorylated at Thr668 (or the corresponding position on other isoforms).
WB
Western blot (WB) analysis of p-APP/beta-Amyloid (T668) pAb at 1:500 dilution
Lane1:MCF-7 cell lysate treated with colchicine
Lane2:Mouse liver tissue lysate
Lane3:Rat liver tissue lysate
IHC
Immunohistochemistry (IHC) analyzes of p-APP/beta-Amyloid (T668) pAb in paraffin-embedded human colorectal carcinoma tissue at 1:50.
BiowMW
ca. 70 to140 kDa
Note
For research use only, not for use in diagnostic procedure.
Alternative Name
Amyloid beta A4 protein, ABPP, APPI, Short name=APP, Alzheimer disease amyloid protein, Cerebral vascular amyloid peptide, Short name=CVAP, PreA4, Protease nexin-II, Short name=PN-II, N-APP, Soluble APP-alpha, Short name=S-APP-alpha, Soluble APP-beta, Short name=S-APP-beta, Beta-amyloid protein 42, Beta-APP42, Beta-amyloid protein 40, Beta-APP40, P3(42), P3(40), Gamma-secretase C-terminal fragment 59, Amyloid intracellular domain 59, Short name=AICD-59, Short name=AID(59), Gamma-CTF(59), Gamma-secretase C-terminal fragment 57, Amyloid intracellular domain 57, Short name=AICD-57, Short name=AID(57), Gamma-CTF(57), Gamma-secretase C-terminal fragment 50, Amyloid intracellular domain 50, AICD-50, AID(50), Gamma-CTF(50), APP, A4, AD, Amyloid-beta, Amyloid beta, Amyloidbeta, beta Amyloid, betaAmyloid, Abeta
Immunogen
Synthetic phosphopeptide derived from human APP/beta-Amyloid around the phosphorylation site of Threonine 668.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100ul
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close